SERA PROGNOSTICS, INC. Proceeds from Stock Options Exercised
SERA PROGNOSTICS, INC. (SERA) reported Proceeds from Stock Options Exercised of $63.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-12
- SERA PROGNOSTICS, INC. proceeds from stock options exercised for the quarter ending 2026-06-30 was $41.00K, a 4000.00% increase year-over-year.
- SERA PROGNOSTICS, INC. proceeds from stock options exercised for the quarter ending 2026-03-31 was $22.00K, a 53.19% decline year-over-year.
- SERA PROGNOSTICS, INC. proceeds from stock options exercised for the quarter ending 2025-12-31 was $66.00K, a 74.02% decline year-over-year.
- SERA PROGNOSTICS, INC. proceeds from stock options exercised for the quarter ending 2025-09-30 was $393.00K, a 72.37% increase year-over-year.
- SERA PROGNOSTICS, INC. proceeds from stock options exercised for fiscal 2025 was $507.00K, a 82.53% decline from fiscal 2024.
- SERA PROGNOSTICS, INC. proceeds from stock options exercised for fiscal 2024 was $2.90M, a 165.02% increase from fiscal 2023.
- SERA PROGNOSTICS, INC. proceeds from stock options exercised for fiscal 2023 was $1.09M, a 255.52% increase from fiscal 2022.
- SERA PROGNOSTICS, INC. proceeds from stock options exercised for fiscal 2022 was $308.00K, a 47.97% decline from fiscal 2021.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2026-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $63.00K 10-Q · filed 2026-08-12 | $129.00K derived: sum of 3 quarters · filed 2026-08-12 | $522.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $22.00K 10-Q · filed 2026-05-06 | $88.00K derived: sum of 2 quarters · filed 2026-05-06 | $481.00K derived: sum of 3 quarters · filed 2026-05-06 | $482.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $459.00K derived: sum of 2 quarters · filed 2026-03-18 | $460.00K derived: sum of 3 quarters · filed 2026-08-12 | $507.00K 10-K · filed 2026-03-18 |
| 2025-09-30 | $393.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $394.00K derived: sum of 2 quarters · filed 2026-08-12 | $441.00K 10-Q · filed 2025-11-13 | $695.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $48.00K 10-Q · filed 2026-08-12 | $302.00K derived: sum of 3 quarters · filed 2026-08-12 | $530.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $47.00K 10-Q · filed 2026-05-06 | $301.00K derived: sum of 2 quarters · filed 2026-05-06 | $529.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.79M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $254.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $482.00K derived: sum of 2 quarters · filed 2026-03-18 | $1.74M derived: sum of 3 quarters · filed 2026-03-18 | $2.90M 10-K · filed 2026-03-18 |
| 2024-09-30 | $228.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.49M derived: sum of 2 quarters · filed 2025-11-13 | $2.65M 10-Q · filed 2025-11-13 | $3.32M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $2.42M 10-Q · filed 2025-08-06 | $3.09M derived: sum of 3 quarters · filed 2025-08-06 | $3.33M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $1.16M 10-Q · filed 2025-05-07 | $1.83M derived: sum of 2 quarters · filed 2025-05-07 | $2.08M derived: sum of 3 quarters · filed 2025-05-07 | $2.25M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $669.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $913.00K derived: sum of 2 quarters · filed 2025-03-19 | $1.09M derived: sum of 3 quarters · filed 2025-03-19 | $1.09M 10-K · filed 2025-03-19 |
| 2023-09-30 | $244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $422.00K derived: sum of 2 quarters · filed 2024-11-06 | $426.00K 10-Q · filed 2024-11-06 | $427.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $178.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $182.00K 10-Q · filed 2024-08-07 | $183.00K derived: sum of 3 quarters · filed 2024-08-07 | $276.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $4.00K 10-Q · filed 2024-05-08 | $5.00K derived: sum of 2 quarters · filed 2024-05-08 | $98.00K derived: sum of 3 quarters · filed 2024-05-08 | $223.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $94.00K derived: sum of 2 quarters · filed 2024-03-20 | $219.00K derived: sum of 3 quarters · filed 2024-03-20 | $308.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | $93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $218.00K derived: sum of 2 quarters · filed 2023-11-08 | $307.00K 10-Q · filed 2023-11-08 | $362.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $214.00K 10-Q · filed 2023-08-09 | $269.00K derived: sum of 3 quarters · filed 2023-08-09 | $542.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $89.00K 10-Q · filed 2023-05-10 | $144.00K derived: sum of 2 quarters · filed 2023-05-10 | $417.00K derived: sum of 3 quarters · filed 2023-05-10 | $452.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $328.00K derived: sum of 2 quarters · filed 2023-03-22 | $363.00K derived: sum of 3 quarters · filed 2023-03-22 | $592.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $273.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $308.00K derived: sum of 2 quarters · filed 2022-11-09 | $537.00K 10-Q · filed 2022-11-09 | $634.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $264.00K 10-Q · filed 2022-08-10 | $361.00K derived: sum of 3 quarters · filed 2022-08-10 | $439.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $229.00K 10-Q · filed 2022-05-10 | $326.00K derived: sum of 2 quarters · filed 2022-05-10 | $404.00K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $175.00K derived: sum of 2 quarters · filed 2022-03-29 | $176.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $79.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $1.00K 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |